Clinical Trials Logo

Cesarean Delivery clinical trials

View clinical trials related to Cesarean Delivery.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06303245 Recruiting - Clinical trials for Cesarean Section; Complications, Wound, Dehiscence

Effects of Abdominal Binders and TENS on Puerperium Period After Cesarean Section

Start date: February 23, 2023
Phase: N/A
Study type: Interventional

To determine the combined effects of abdominal binders and TENS on post-operative pain, distress and constipation in puerperium period after cesarean section

NCT ID: NCT06247852 Recruiting - Chronic Pain Clinical Trials

Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study

Start date: September 1, 2023
Phase:
Study type: Observational

In Denmark, around 12,700 patients undergo Cesarean delivery (CD) annually, constituting approximately 20% of all childbirths in the country. Worldwide, the number is increasing each year, with more than 20 million CD performed annually. Postoperative pain after CD is typically moderate to severe in intensity and still constitutes a significant challenge, balancing effective pain relief and potential side effects. Correlations between moderate to severe acute pain and the development of persistent pain after CD is still unclear. Postsurgical persistent pain is a significant, often unrecognized clinical problem that causes distress and diminishes the quality of life for patients. Despite advances in understanding the factors contributing to persistent postsurgical pain and an increased focus on identifying patients at risk, the management and prevention of postsurgical persistent pain are still inadequate. It is important to gain further insights into this population, and we have a unique opportunity to do so by following the national cohort from the ongoing Danish multicenter cohort study on pain after cesarean section (ClinicalTrials.gov Identifier: NCT06012747) over an extended follow-up period. This involves continued prospective registration of Patient-Reported Outcome Measures (PROM) collected by SMS-based questionnaires in the months and years after the CD, thereby investigating the occurrence of both acute and persistent pain after CD. The outcomes are focused on pain levels, the impact of pain on physical function and neuropathic pain characteristics in the months and years following the CD. The study also aims to explore the relationship between persistent and acute pain.

NCT ID: NCT06199245 Recruiting - Breastfeeding Clinical Trials

The Effect of Emotional Freedom Technique on Breastfeeding Success and Self-Efficacy

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

This study was planned to determine the effect of emotional freedom technique (EFT) on breastfeeding success and self-efficacy in primiparous women in the early postpartum period who had a cesarean delivery.

NCT ID: NCT06181396 Recruiting - Clinical trials for Delivery Complication

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.

NCT ID: NCT06030063 Recruiting - General Anesthesia Clinical Trials

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Start date: February 22, 2024
Phase:
Study type: Observational

The SOAP registry is a prospective, multicenter, electronic registry. The goal is to investigate the indications, mode of airway management, predisposing factors, and obstetric and anesthetic outcomes of pregnant patients who receive general anesthesia for cesarean delivery.

NCT ID: NCT05661136 Recruiting - Spinal Anesthesia Clinical Trials

Maternal Postop Temperature After Cesarean Delivery

Start date: December 13, 2022
Phase: N/A
Study type: Interventional

It is unclear whether routine addition of intra-operative forced-air warming in addition to warmed intravenous fluids during cesarean delivery under spinal anesthesia is beneficial. In this single-center randomized trial, we aim to test the primary null hypothesis that our current protocol of warmed intravenous fluids is similar to a combination of warmed intravenous fluids with intra-operative lower-body forced-air warming to maintain maternal temperature after cesarean delivery under spinal anesthesia. We also aim to assess the rate of maternal shivering during and after the procedure between the two groups, the maternal thermal comfort score, neonatal Apgar scores and umbilical pH levels. If we demonstrate no clinically important difference between the two interventions, clinicians will be able to continue our current protocol of warmed intravenous fluids only during cesarean delivery.

NCT ID: NCT05342376 Recruiting - Cesarean Delivery Clinical Trials

Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.

Start date: February 1, 2022
Phase: Phase 4
Study type: Interventional

Intraoperative and post operative shivering is a common problem encountered in operating rooms and recovery suites. Shivering under spinal anesthesia has an incidence of 40-60%. Shivering is not only uncomfortable for the patient; additionally it increases minute oxygen consumption, subjecting the patient to a higher risk of cardiovascular complications. A variety of drugs like pethidine, fentanyl, alfentanil, sufentanil, buprenorphine, doxapram, clonidine, and ketanserin, are reported to be effective in suppressing postoperative shivering, yet an ideal drug/ method to be explored. Dexmeditomidine, a sedative and analgesic, may control shivering without significant adverse effects, like nausea and vomitting and respiratory depression. The study design will be randomized controlled parallel trials with sample size of 80,They will be randomized into two equal groups. One group will receive 10 microgram Inj. Dexmeditomedine while the other will recieve inj. normal saline as placebo. The participants will be assessed for intra- and postoperative shivering.

NCT ID: NCT05279703 Recruiting - Cesarean Delivery Clinical Trials

Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery

Start date: March 21, 2022
Phase: Phase 4
Study type: Interventional

Maternal hypotension after spinal block is a common complication after subarachnoid block in this population. The incidence of maternal hypotension is nearly 60% when prophylactic vasopressors are not used. Therefore, it is highly recommended to use vasopressors, preferably as continuous infusion, for prophylaxis rather than delaying their use until hypotension occurs. Phenylephrine (PE) is the recommended drug for prophylaxis against hypotension during cesarean delivery; however, the use of PE is commonly associated with decreased heart rate and probably cardiac output because PE is a pure alpha adrenoreceptor agonist. Introduction of NE in obstetric practice had shown favorable maternal and neonatal outcomes and was associated with higher heart rate and cardiac output compared to PE. However, there is still some mothers who develop bradycardia and diminished cardiac output with the use of NE. The most desired scenario during hemodynamic management of mothers during cesarean delivery would achieve the least possible incidences of maternal hypotension, bradycardia and reactive hypertension. Therefore, it is warranted to reach a vasopressor regimen with the most stable hemodynamic profile. In the last year, epinephrine was reported for the first time in obstetric practice with acceptable safety on the mother and the fetus. However, there is still lack of data about the most appropriate dose for infusion during cesarean delivery. This study aims to compare three prophylactic infusion rates for epinephrine during cesarean delivery.

NCT ID: NCT04993651 Recruiting - Morbid Obesity Clinical Trials

Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women

Start date: October 11, 2021
Phase: N/A
Study type: Interventional

The objective of our study is to evaluate the effect of CPAP on umbilical cord acid base status in morbidly obese women at the time of scheduled cesarean delivery. We hypothesize that neonates born to mothers wearing CPAP during the cesarean section will have a higher umbilical artery pH.

NCT ID: NCT04159948 Recruiting - Fasting Clinical Trials

Preoperative Carbohydrate Drink Prior to Elective Caesarean Section

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

Prior to caesarean section, patients should fast from solid food for 6 hours and from clear fluids for 2 hours. Carbohydrate drinks can also be consumed up to 2 hours before surgery. These drinks have been shown to improve patient well-being after surgery and may potentially improve the neonatal blood glucose level after delivery and reduce the risk of a low blood glucose level. This study aims to assess the influence of pre-operative carbohydrate drinks on blood glucose levels of the baby at delivery.